Dr. Eric Martin McDade, DO

Dr. McDade practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. McDade's NPI, 1073649265, was assigned on February 24, 2007. Dr. McDade graduated from Midwestern University, Chicago College of Osteopathic Med in 2004. Dr. McDade holds Missouri license 2016000355.

Dr. McDade's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. McDade also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. McDade's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. McDade is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. McDade to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McDade practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. McDade's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. McDade is licensed in Missouri.

CMS data shows 79 Medicare services from Dr. McDade across 4 procedure codes in 2024, for 85 Medicare patients. Medicare paid $6,177 for them.

CMS counts 85 Medicare patients who saw Dr. McDade in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McDade's median patient age at 75, with 51% women.

In 2024, Dr. McDade wrote 283 Medicare Part D claims for 59 patients. 98% of them were for generic drugs. CMS names the drug for 220 of them, across 7 drugs with 11 or more claims each, at $7,243 in total drug cost. In 2023, CMS named 253 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. McDade for performance year 2024, reported as part of a group. Dr. McDade accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 153 papers to Dr. McDade, published from 2011 to 2025. 2023 was the busiest year, with 18. The most frequent topics are Alzheimer Disease, Amyloid beta-Peptides and Positron-Emission Tomography. Dr. McDade has published most often in Alzheimers Dement. Dr. McDade's most frequent co-authors are Gregory Scott Day, MD, James McCallum Noble, MD and Sarah Beth Berman.

CMS Open Payments shows 62 general payments to Dr. McDade from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Eli Lilly and Company paid the most, $21,325.

Dr. McDade graduated from Midwestern University, Chicago College of Osteopathic Med in 2004.